Latest Insider Transactions at Schwab Charles Corp (SCHW)
This section provides a real-time view of insider transactions for Schwab Charles Corp (SCHW). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of SCHWAB CHARLES CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of SCHWAB CHARLES CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 03
2025
|
Carolyn Schwab Pomerantz Director |
SELL
Open market or private sale
|
Indirect |
24,000
-1.48%
|
$2,184,000
$91.59 P/Share
|
|
Jul 01
2025
|
Jonathan S Beatty MD, Head of Advisor Services |
SELL
Payment of exercise price or tax liability
|
Direct |
1,035
-2.33%
|
$93,150
$90.74 P/Share
|
|
Jul 01
2025
|
Paul V Woolway MD, Chief Banking Officer |
SELL
Open market or private sale
|
Indirect |
3,290
-8.4%
|
$296,100
$90.95 P/Share
|
|
Jun 24
2025
|
Stephen A Ellis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,853
+21.77%
|
$61,149
$33.12 P/Share
|
|
Jun 18
2025
|
Nigel J Murtagh Chief Risk Officer |
SELL
Open market or private sale
|
Direct |
20,872
-26.13%
|
$1,878,480
$90.01 P/Share
|
|
Jun 18
2025
|
Nigel J Murtagh Chief Risk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,872
+20.72%
|
$876,624
$42.99 P/Share
|
|
Jun 18
2025
|
Paul V Woolway MD, Chief Banking Officer |
SELL
Open market or private sale
|
Indirect |
10,129
-20.55%
|
$911,610
$90.01 P/Share
|
|
Jun 18
2025
|
Paul V Woolway MD, Chief Banking Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,129
+23.08%
|
$465,934
$46.81 P/Share
|
|
Jun 05
2025
|
Carolyn Schwab Pomerantz Director |
SELL
Open market or private sale
|
Indirect |
24,000
-1.46%
|
$2,088,000
$87.25 P/Share
|
|
Jun 03
2025
|
Michael D Verdeschi CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,888
-9.84%
|
$512,256
$87.54 P/Share
|
|
Jun 02
2025
|
Paul V Woolway MD, Chief Banking Officer |
SELL
Open market or private sale
|
Indirect |
3,290
-7.75%
|
$286,230
$87.68 P/Share
|
|
May 30
2025
|
Jonathan S Beatty MD, Head of Advisor Services |
SELL
Open market or private sale
|
Indirect |
2,850
-15.77%
|
$247,950
$87.57 P/Share
|
|
May 28
2025
|
Nigel J Murtagh Chief Risk Officer |
SELL
Open market or private sale
|
Direct |
25,000
-29.76%
|
$2,200,000
$88.2 P/Share
|
|
May 28
2025
|
Nigel J Murtagh Chief Risk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+22.94%
|
$1,025,000
$41.98 P/Share
|
|
May 27
2025
|
Todd M Ricketts Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,462
+0.38%
|
-
|
|
May 27
2025
|
Gerri Martin Flickinger Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,462
+20.22%
|
-
|
|
May 27
2025
|
Paula A Sneed Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,462
+15.33%
|
-
|
|
May 27
2025
|
Paula A Sneed Director |
SELL
Open market or private sale
|
Indirect |
8,647
-7.57%
|
$760,936
$88.06 P/Share
|
|
May 27
2025
|
Charles A. Ruffel Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,462
+7.47%
|
-
|
|
May 27
2025
|
Arun Sarin Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,462
+12.05%
|
-
|
|
May 27
2025
|
Carolyn Schwab Pomerantz Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,462
+13.19%
|
-
|
|
May 27
2025
|
Stephen A Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,462
+13.92%
|
-
|
|
May 27
2025
|
Frank C Herringer Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,462
+12.05%
|
-
|
|
May 27
2025
|
Marianne Catherine Brown Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,462
+8.49%
|
-
|
|
May 27
2025
|
Joan Dea Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,462
+4.93%
|
-
|
|
May 27
2025
|
Christopher V Dodds Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,462
+12.05%
|
-
|
|
May 27
2025
|
John K Adams Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,462
+2.92%
|
-
|
|
May 22
2025
|
Charles R. Schwab Co-Chairman |
SELL
Open market or private sale
|
Indirect |
34,585
-0.06%
|
$3,008,895
$87.5 P/Share
|
|
May 22
2025
|
Peter J. Morgan Iii General Counsel |
SELL
Open market or private sale
|
Direct |
10,176
-100.0%
|
$885,312
$87.39 P/Share
|
|
May 21
2025
|
Jonathan M. Craig MD, Head of Investor Services |
SELL
Open market or private sale
|
Indirect |
47,500
-100.0%
|
$4,180,000
$88.46 P/Share
|
|
May 21
2025
|
Jonathan M. Craig MD, Head of Investor Services |
BUY
Exercise of conversion of derivative security
|
Direct |
47,500
+100.0%
|
$1,947,500
$41.98 P/Share
|
|
May 21
2025
|
Charles A. Ruffel Director |
SELL
Open market or private sale
|
Direct |
5,556
-25.08%
|
$483,372
$87.65 P/Share
|
|
May 19
2025
|
Walter W Bettinger Co-Chairman |
SELL
Open market or private sale
|
Direct |
191,523
-20.03%
|
$17,045,547
$89.0 P/Share
|
|
May 16
2025
|
Carolyn Schwab Pomerantz Director |
SELL
Open market or private sale
|
Indirect |
18,010
-1.08%
|
$1,584,880
$88.74 P/Share
|
|
May 13
2025
|
Charles R. Schwab Co-Chairman |
SELL
Bona fide gift
|
Indirect |
80,000
-0.14%
|
-
|
|
May 12
2025
|
Charles R. Schwab Co-Chairman |
SELL
Open market or private sale
|
Indirect |
120,000
-0.2%
|
$10,200,000
$85.39 P/Share
|
|
May 09
2025
|
Richard A Wurster President & CEO |
SELL
Open market or private sale
|
Direct |
15,345
-7.95%
|
$1,288,980
$84.08 P/Share
|
|
May 08
2025
|
Paul V Woolway MD, Chief Banking Officer |
SELL
Open market or private sale
|
Indirect |
8,613
-16.87%
|
$732,105
$85.0 P/Share
|
|
May 08
2025
|
Paul V Woolway MD, Chief Banking Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,613
+20.32%
|
$353,133
$41.98 P/Share
|
|
May 08
2025
|
Charles R. Schwab Co-Chairman |
SELL
Bona fide gift
|
Indirect |
6,000
-0.01%
|
-
|
|
May 08
2025
|
Nigel J Murtagh Chief Risk Officer |
SELL
Open market or private sale
|
Direct |
25,000
-29.76%
|
$2,125,000
$85.0 P/Share
|
|
May 08
2025
|
Nigel J Murtagh Chief Risk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+22.94%
|
$1,050,000
$42.99 P/Share
|
|
May 08
2025
|
Jonathan S Beatty MD, Head of Advisor Services |
SELL
Open market or private sale
|
Indirect |
3,658
-16.84%
|
$310,930
$85.0 P/Share
|
|
May 08
2025
|
Jonathan S Beatty MD, Head of Advisor Services |
BUY
Exercise of conversion of derivative security
|
Direct |
3,658
+7.62%
|
$160,952
$44.24 P/Share
|
|
May 07
2025
|
Charles R. Schwab Co-Chairman |
SELL
Bona fide gift
|
Indirect |
62,500
-0.11%
|
-
|
|
May 06
2025
|
Nigel J Murtagh Chief Risk Officer |
SELL
Bona fide gift
|
Direct |
121
-0.2%
|
-
|
|
May 06
2025
|
Charles R. Schwab Co-Chairman |
SELL
Bona fide gift
|
Indirect |
80,000
-0.14%
|
-
|
|
May 05
2025
|
Richard A Wurster President & CEO |
SELL
Bona fide gift
|
Direct |
2,877
-1.47%
|
-
|
|
May 05
2025
|
Charles R. Schwab Co-Chairman |
SELL
Bona fide gift
|
Indirect |
75,000
-0.13%
|
-
|
|
May 01
2025
|
Paul V Woolway MD, Chief Banking Officer |
SELL
Open market or private sale
|
Indirect |
11,994
-11.6%
|
$971,514
$81.58 P/Share
|